Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||
| Net Income | -25,360 | -12,366 | -10,600 |
| Depreciation Amortization | 7,557 | 3,175 | 1,100 |
| Accounts receivable | 1,685 | -2,348 | N/A |
| Accounts payable and accrued liabilities | 431 | 399 | N/A |
| Other Working Capital | -1,215 | 931 | 4,230 |
| Other Operating Activity | 5,314 | 2,378 | 200 |
| Operating Cash Flow | $-11,588 | $-7,831 | $-5,070 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -3,962 | N/A | N/A |
| PPE Investments | -3,617 | -7,086 | -2,380 |
| Investing Cash Flow | $-7,579 | $-7,086 | $-2,380 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 3,471 | 6,696 | N/A |
| Debt Repayment | -2,412 | -1,415 | N/A |
| Common Stock Issued | 45,837 | 51 | N/A |
| Other Financing Activity | 15,465 | 5,928 | 7,800 |
| Financing Cash Flow | $62,361 | $11,260 | $7,800 |
| Beginning Cash Position | 5,836 | 9,493 | 9,140 |
| End Cash Position | 49,030 | 5,836 | 9,490 |
| Net Cash Flow | $43,194 | $-3,657 | $340 |
| Free Cash Flow | |||
| Operating Cash Flow | -11,588 | -7,831 | -5,070 |
| Capital Expenditure | -3,617 | -7,086 | N/A |
| Free Cash Flow | -15,205 | -14,917 | -5,070 |